Category:
Sera and Vaccines
CAS NO:
119413-54-6
Standard:
ChP,IP,
Compared with camptothecin, Topotecan hydrochloride has lower toxicity and higher anti-tumor activity. It was approved for market in 1996 and is clinically used for the treatment of advanced colon cancer, rectal cancer, ovarian cancer and small cell lung cancer